Lowered levels of microRNA-129 and potential signaling pathways in papillary thyroid carcinoma: a determination of microRNA sequencing in 507 patients and bioinformatics analysis.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International Journal of Clinical and Experimental Pathology

• Publication date

  2017-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 31966595PMCID PMC6965262
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer

  2017cited by this paper
• Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B.

  2017cited by this paper
• microRNA target prediction programs predict many false positives

  2017cited by this paper
• AB064. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer

  2017cited by this paper
• A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors

  2017cited by this paper
• Inverse expression of caveolin-1 and EGFR in thyroid cancer patients.

  2017cited by this paper
• MicroRNA-146a Ameliorates Inflammation via TRAF6/NF-κB Pathway in Intervertebral Disc Cells

  2017cited by this paper
• microRNA-137 is downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR

  2016cited by this paper
• Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma

  2016cited by this paper
• MiR-129-5p-mediated Beclin-1 suppression inhibits endothelial cell autophagy in atherosclerosis.

  2016cited by this paper
• MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2

  2016cited by this paper
• MiR-129-5p is down-regulated and involved in migration and invasion of gastric cancer cells by targeting interleukin-8.

  2016cited by this paper
• Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer

  2016cited by this paper
• Variants in microRNA genes in familial papillary thyroid carcinoma

  2016cited by this paper
• Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules

  2016cited by this paper
• MicroRNA-129 in Human Cancers: from Tumorigenesis to Clinical Treatment

  2016cited by this paper
• An Appraisal of Proliferation and Apoptotic Markers in Papillary Thyroid Carcinoma: An Automated Analysis

  2016cited by this paper
• miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.

  2016cited by this paper
• Increased Pleiotrophin Concentrations in Papillary Thyroid Cancer

  2016cited by this paper
• The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence

  2016cited by this paper
• MiR-129 triggers autophagic flux by regulating a novel Notch-1/ E2F7/Beclin-1 axis to impair the viability of human malignant glioma cells

  2016cited by this paper
• Tools for Sequence-Based miRNA Target Prediction: What to Choose?

  2016cited by this paper
• Cancer stem cells as a potential therapeutic target in thyroid carcinoma.

  2016cited by this paper
• MicroRNAs modulating angiogenesis: miR-129-1 and miR-133 act as angio-miR in HUVECs

  2016cited by this paper
• Downregulation of miR-129-2 by promoter hypermethylation regulates breast cancer cell proliferation and apoptosis.

  2016cited by this paper
• Predictive significance of thyroid transcription factor-1 expression in patients with non-squamous non-small cell lung cancer with wild-type epidermal growth factor receptor treated with erlotinib.

  2016cited by this paper
• Cancer stem cells as a potential therapeutic target in thyroid carcinoma (Review)

  2016cited by this paper
• Overexpression of long non-coding RNA NR_036575.1 contributes to the proliferation and migration of papillary thyroid cancer

  2016cited by this paper
• MicroRNA-129-5p inhibits vascular smooth muscle cell proliferation by targeting Wnt5a.

  2016cited by this paper
• miR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma

  2016cited by this paper
• Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.

  2015cited by this paper
• MicroRNA profiling identifies miR-129-5p as a regulator of EMT in tubular epithelial cells.

  2015cited by this paper
• Role of GPER1, EGFR and CXCR1 in differentiating between malignant follicular thyroid carcinoma and benign follicular thyroid adenoma.

  2015cited by this paper
• Expression of FHIT, p16, p53 and EGFR as prognostic markers in thyroid tumors of uncertain malignant potential.

  2015cited by this paper
• Thyroid transcription factor-1 expression is significantly associated with mutations in exon 21 of the epidermal growth factor receptor gene in Chinese patients with lung adenocarcinoma

  2015cited by this paper
• Characterization of the novel tumor-suppressor gene CCDC67 in papillary thyroid carcinoma

  2015cited by this paper
• mir-129-5p Attenuates Irradiation-Induced Autophagy and Decreases Radioresistance of Breast Cancer Cells by Targeting HMGB1

  2015cited by this paper
• Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model

  2015cited by this paper
• Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer

  2015cited by this paper
• MiR‐129‐5p is down‐regulated and involved in the growth, apoptosis and migration of medullary thyroid carcinoma cells through targeting RET

  2014influential reference
• MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells.

  2011cited by this paper

• Intracellular cGMP increase is not involved in thyroid cancer cell death

  2023influential citation
• Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer

  2022cites this paper
• Overexpression of mir-129-1, miR-146b, mir-183, and mir-197 in follicular thyroid carcinoma and adenoma tissues.

  2020cites this paper
• Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B.

  2017cites this paper
• microRNA-137 is downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR

  2016cites this paper
• MiR-129-5p-mediated Beclin-1 suppression inhibits endothelial cell autophagy in atherosclerosis.

  2016cites this paper